Global Health Crisis: Just 7% of Lives Saved, Billions for Bombs
The Independent reveals an HIV 'vaccine' (lenacapavir) will only reach 7% of the people required to end the AIDS pandemic, partly due to cost and collapsed prevention services. A UN report calls the situation 'devastating.' Meanwhile, the US Congress routinely debates and approves billions for military aid. For example, in 2023 alone, Congress debated providing more than $14 billion in additional
military assistance to Israel (e.g., HR 815), funds that seemingly materialize with fewer logistical hurdles than global health initiatives. One might wonder if preventing a pandemic gets the same urgent attention as supplying weapons. While Gilead Sciences, Inc.—producer of lenacapavir—reported $27.1 billion in revenue in 2023, the 'devastating' collapse of HIV prevention services continues. It
would appear some interventions are simply more 'critical' to national interests than the survival of millions in the Global South.